NOVAREX Co.Ltd (194700) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.041x

Based on the latest financial reports, NOVAREX Co.Ltd (194700) has a cash flow conversion efficiency ratio of 0.041x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.73 Billion ≈ $7.27 Million USD) by net assets (₩260.64 Billion ≈ $176.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NOVAREX Co.Ltd net asset quality index to measure how much of total assets are equity-financed.

NOVAREX Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how NOVAREX Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 194700 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

NOVAREX Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NOVAREX Co.Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Leatec Fine Ceramics Co Ltd
TWO:6127
0.003x
Biomm S.A
SA:BIOM3
-0.164x
ES Cube Co. Ltd
KQ:050120
-0.025x
ADTechnology Co.Ltd
KQ:200710
-0.090x
DYNACOR GROUP INC.
F:OA5
0.011x
Sajo Ind
KO:007160
-0.007x
Perfect Corp.
NYSE:PERF
0.027x
Venu Holding Corporation
NYSE MKT:VENU
0.065x

Annual Cash Flow Conversion Efficiency for NOVAREX Co.Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of NOVAREX Co.Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see 194700 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩254.64 Billion
≈ $172.57 Million
₩16.65 Billion
≈ $11.28 Million
0.065x +8.25%
2024-12-31 ₩220.26 Billion
≈ $149.27 Million
₩13.31 Billion
≈ $9.02 Million
0.060x -52.15%
2023-12-31 ₩200.42 Billion
≈ $135.82 Million
₩25.30 Billion
≈ $17.15 Million
0.126x +13.88%
2022-12-31 ₩181.37 Billion
≈ $122.91 Million
₩20.11 Billion
≈ $13.63 Million
0.111x -35.83%
2021-12-31 ₩139.67 Billion
≈ $94.65 Million
₩24.13 Billion
≈ $16.35 Million
0.173x +22.84%
2020-12-31 ₩115.61 Billion
≈ $78.35 Million
₩16.26 Billion
≈ $11.02 Million
0.141x +1093.29%
2019-12-31 ₩91.79 Billion
≈ $62.21 Million
₩-1.30 Billion
≈ $-880.82K
-0.014x -115.01%
2018-12-31 ₩78.93 Billion
≈ $53.49 Million
₩7.44 Billion
≈ $5.04 Million
0.094x -53.95%
2017-12-31 ₩51.88 Billion
≈ $35.16 Million
₩10.62 Billion
≈ $7.20 Million
0.205x +23.86%
2016-12-31 ₩44.62 Billion
≈ $30.24 Million
₩7.38 Billion
≈ $5.00 Million
0.165x -31.13%
2015-12-31 ₩36.31 Billion
≈ $24.61 Million
₩8.72 Billion
≈ $5.91 Million
0.240x --

About NOVAREX Co.Ltd

KQ:194700 Korea Packaged Foods
Market Cap
$164.24 Million
₩242.35 Billion KRW
Market Cap Rank
#17263 Global
#659 in Korea
Share Price
₩13650.00
Change (1 day)
-2.50%
52-Week Range
₩11600.00 - ₩21050.00
All Time High
₩23604.80
About

NOVAREX Co.,Ltd. manufactures, wholesales, and retails health and functional foods in South Korea and internationally. It offers lactic acid bacteria, omega-3, icle time, eye health, diet, boswellia, and lutein and zeaxanthin, as well as vitamin and mineral products in the form of tablets, soft and hard capsules, powder, liquid, gel, and jellies. The company was formerly known as Health Science C… Read more